Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

line portfolio 115 14.18 Astellas Pharma 115 14.18.1 Overview 115 14.18.2 IBS Pipeline Portfolio 115 15 Gastrointestinal Disorder Therapeutics Market: Pipeline Analysis 118 15.1 Preclinical 119 15.2 Phase I 120 15.3 Pipeline II 122 15.4 Phase III 126 15.5 Promising Drugs under Clinical Development for Crohn's Disease 129 15.5.1 Myoconda 129 15.5.2 Traficet-EN (CCX282) 129 15.5.3 MLN0002 (vedolizumab) 129 15.5.4 Orencia (abatacept) 129 15.5.5 ABT-874 129 15.5.6 Stelara 129 15.6 Promising Drugs under Clinical Development for Irritable Bowel Syndrome 130 15.6.1 Linaclotide (Linaclotide Acetate) 130 15.6.2 Asimadoline 130 15.6.3 Xifaxan (Rifaximin) 130 15.6.4 Bifantis (Bifidobacterium infantis 35624) 130 15.6.5 LX-103 131 15.6.6 YM060 (Ramosetron hydrochloride) 131 15.7 Promising Drugs under Clinical Development for GERD 131 15.7.1 XP19986 131 15.7.2 AZD3355 131 15.7.3 ADX10059 132 15.7.4 Vecam 132 15.8 Promising Drugs under Clinical Development for Ulcerative Colitis 132 15.8.1 Prograf (Tacrolimus) 132 15.8.2 Vedolizumab 132 15.8.3 Abatacept 132 15.8.4 Adalimumab 133 15.8.5 Golimumab 133 16 Global Gastrointestinal Disorder Therapeutics Market: Strategic Consolidations 134 16.1 Mergers and Acquisitions 134 16.1.1 Overview 134 16.1.2 GlaxoSmithKline Acquires AZ Tika Of AstraZeneca 134 16.1.3 ViroPharma Acquires Lev Pharmaceuticals 134 16.1.4 UCB Acquires Remaining Stake In Schwarz Pharma 134 16.1.5 Teva Pharmaceutical Acquires Bentley Pharmaceuticals 134 16.1.6 Gilead Sciences Acquires Nycomed Limited 135 16.2 Licensing Agreements 135 16.2.1 Overview 135 17 Global Gastrointestinal Disorder Therapeutics Market : Appendix 138 17.1 Market Definitions 138 17.2 Abbreviations 138 17.3 Research Methodology 139 17.3.1 Coverage 139 17.3.2 Secondary Research 139 17.3.3 Pri
'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 The National ... patient,s eyes—and life—were saved by doctors at Vanderbilt University ... with NNFF, NovaBay Pharmaceuticals and Dr. John Crew ... at Seton Medical Center in Daly ... used a breakthrough approach, pioneered by Dr. Crew, that ...
(Date:8/27/2015)... 27, 2015 HUYA Bioscience International (HUYA) today announced ... Japan Society of HTLV-1, held this week at the ... of the Society is to promote research on HTLV-1 ... medical technology and research related to these fields to ... "HUYA is proud to support this prestigious conference," said ...
(Date:8/27/2015)... ... August 27, 2015 , ... METTLER TOLEDO's web-based ... down the product choices to a manageable shortlist of bench and floor scales ... models that fit best with the customer’s industry and application. , Side-by-side ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, a leader in ... is to open in Manhattan, Kansas in early October, 2015. The location of ... research and development through collaboration with researchers from Kansas State University’s College of ...
Breaking Biology Technology:Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4METTLER TOLEDO Updates Online Scale Selection Tool 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3
... 1 Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ), ... developing novel medicines in the areas of hepatitis ... the third quarter ended,September 30, 2007 and operational ... an important transition for Anadys,",said Steve Worland, Ph.D., ...
... Growth of 58.9% Year-over-Year, SHENZHEN, China, Nov. ... MR ), a leading developer, manufacturer,and marketer of ... presence, today announced its selected unaudited financial,results for ... Highlights for Third Quarter 2007, -- Third ...
... Healthcare (Nasdaq: MRGE ; TSX: MRG), today,announced that ... Qualifications Panel stating that the panel determined to continue,the ... Stock Market,subject to the Company,s filing of its Form ... later than January 29, 2008. As indicated in the ...
Cached Biology Technology:Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 2Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 3Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 4Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 5Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 6Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 7Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 8Anadys Pharmaceuticals Reports Third Quarter 2007 Financial Results and Operational Highlights 9Mindray Medical International Announces Third Quarter 2007 Results 2Mindray Medical International Announces Third Quarter 2007 Results 3Mindray Medical International Announces Third Quarter 2007 Results 4Mindray Medical International Announces Third Quarter 2007 Results 5Mindray Medical International Announces Third Quarter 2007 Results 6Mindray Medical International Announces Third Quarter 2007 Results 7Mindray Medical International Announces Third Quarter 2007 Results 8Mindray Medical International Announces Third Quarter 2007 Results 9Mindray Medical International Announces Third Quarter 2007 Results 10Mindray Medical International Announces Third Quarter 2007 Results 11Mindray Medical International Announces Third Quarter 2007 Results 12Mindray Medical International Announces Third Quarter 2007 Results 13Mindray Medical International Announces Third Quarter 2007 Results 14Mindray Medical International Announces Third Quarter 2007 Results 15Mindray Medical International Announces Third Quarter 2007 Results 16Mindray Medical International Announces Third Quarter 2007 Results 17Mindray Medical International Announces Third Quarter 2007 Results 18Mindray Medical International Announces Third Quarter 2007 Results 19Mindray Medical International Announces Third Quarter 2007 Results 20NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance 2NASDAQ Panel Grants Merge Technologies Additional Time to Regain Compliance 3
(Date:8/6/2015)... and TELTOW, Germany , ... 2015 Siggraph Conference, SensoMotoric Instruments (SMI) shows ... reality , based on Epson,s Moverio BT-200 ... tracking platform. With this new solution, unprecedented quality and ... hands-free interaction with context-sensitive displays. For the first time, ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
(Date:7/31/2015)... , 31 de julho de 2015 A ... www.icg-10.org ) será realizada pela BGI de 22-25 de outubro ... A conferência está celebrando seu 10 o. ... a ICG se tornou uma das reuniões mais influentes ... encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... Northwestern University scientist Mary J.C. Hendrix and colleagues ... skin cells nor less aggressive melanoma cells) contain ... stem cells. This groundbreaking work led to ... may help to explain how, by becoming more ...
... feathers may add value to the poultry industry ... plastic waste. , According to the U.S. Environmental ... non-biodegradable plastic waste ends up in landfills each ... engineering at Virginia Tech, is investigating ways to ...
... cells that can repair the most severe damage to the ... lie around and do nothing, but when neighboring cells die, ... report on the discovery will appear online next week in ... Army Reserves of our nose,?explains lead author Randall Reed, Ph.D., ...
Cached Biology News:Reversing cancer cells to normal cells 2Reversing cancer cells to normal cells 3Researcher examines polymers created with poultry feathers 2When smell cells fail they call in stem cell reserves 2
... stain was developed specifically for reduced mutagenicity ... DNA in agarose or acrylamide gels. SYBR Safe ... bromide but SYBR Safe stain's detection sensitivity is ... stain comes as a premixed solution that can ...
... This exceptionally sensitive nucleic acid gel stain ... low background in gels, making it ideal for ... standard UV transilluminators. SYBR Green I nucleic ... capillary electrophoresis, real-time PCR assays and bandshift ...
... Todays advanced protein cross-linking techniques are ... text, Dr. Shan S. Wong. This valuable ... reaction schemes and current application references. More ... of protein cross-linking and conjugate preparation ...
... proteomic service includes protein separation by ... the PDQuest software package from Bio-Rad ... spectrometry. In order to meet customers ... data analysis and format of the ...
Biology Products: